US Patent 12091397 Dihydroquinolinones for medical treatment
All edits
Edits on 18 Sep, 2024
Golden AI
Edits made to:
Infobox (+28 properties)
Article (+347 characters)
US Patent 12091397 Dihydroquinolinones for medical treatment
Article
Patent abstract
The present invention provides dihydroquinolinone compounds which bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and alter the substrate specificity of the CRBN E3 ubiquitin ligase complex, resulting in breakdown of intrinsic downstream proteins. The disclosed compounds are useful for the treatment of cancer.
Infobox
Is a
Patent Applicant
Patent Jurisdiction
Patent Number
Patent Inventor Names
Adrian Britschgi0
Annick Goergler0
Eric Andre Kusznir0
Fabian Dey0
Moreno Attilio Wichert0
Roger Norcross0
Date of Patent
September 17, 2024
0Patent Application Number
178787530
Date Filed
August 1, 2022
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12091397 Dihydroquinolinones for medical treatment
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.